9.4 C
New York
Sunday, December 3, 2023

Is Resmed Inc. (NYSE: RMD) Still On The Rise?

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. After-hours trades for Resmed Inc. (RMD) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $1.25, or 0.83%, to $151.51. The Resmed Inc. has recorded 13,614 volume in the after hours trading session. Earlier, Yahoo Finance discussed this stock as it revealed ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2024.

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


Stocks Info

Resmed Inc. is listed on the NYSE as a member of the Healthcare sector and is a part of the Medical Instruments & Supplies industry. At the end of the last regular session, the stock closed at $150.26 and fluctuated between $155.07 as its day high and $149.77 as its day low. The current market capitalization of Resmed Inc. is $22.10B. A total of 1.31 million shares were traded on the day, compared to an average of 1.77M shares.

Insider Activity

Additionally, investors take into account insider trades when predicting how a stock will perform. During the recent three months, RMD has seen 8 BUY and 6 SELL insider trades, representing the acquisition of 37,598 and the disposition of 13,280 shares. Over the last 12 months, there were 37 BUYs and 68 SELLs from insiders. Insiders purchased 263,574 shares during that period but sold 227,952.

In the most recent transaction, Rider Michael J sold 25 shares of RMD for 143.42 per share on Nov 01. After the transaction, the Global General Counsel now owns 7,358 company shares. In a previous transaction on Oct 16, Farrell Michael J. sold 5,675 shares at 140.70 per share. RMD shares that Chief Executive Officer owns now total 449,360.

Among the insiders who sold shares, Rider Michael J disposed of 25 shares on Oct 02 at a per-share price of $145.92. This resulted in the Global General Counsel holding 7,383 shares of RMD after the transaction. In another insider transaction, Farrell Michael J. sold 5,675 shares at $146.35 per share on Sep 15. Company shares held by the Chief Executive Officer now total 449,360.


It is more appealing for investors to invest in companies that pay dividends because dividends generate immediate cash flow and indicate a positive outlook for the company. Resmed Inc. pays an annual dividend of $1.94, resulting in a dividend yield of 1.29%, and it has a price to earnings (P/E) ratio of 24.44. RMD’s most recent ex-dividend date was 11/8/2023 when it declared a $0.48 quarterly dividend that was paid in cash on 12/14/2023. Previously, the company paid the dividend on 9/21/2023 with an ex-dividend date of 8/16/2023. The RMD stock dividend was $0.48 per share in cash.

Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. According to analysts who have offered 12-month price targets for RMD in the last 3 months, the mean price target is $192.41 with high estimates of $250.27 and low estimates of $158.00. In terms of 52-week highs and lows, RMD has a high of $243.52 and a low of $132.24.

As of this writing, RMD has an earnings estimate of $1.62 per share for the current quarter. EPS was calculated based on a consensus of 9 estimates, with a high estimate of $1.68 per share and a lower estimate of $1.55. The company reported an EPS of $1.68 in the last quarter, which was 5.70% higher than expectations of $1.59.

Balance Sheet Annually/Quarterly

A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. RMD’s latest balance sheet shows that the firm has $273.71M in Cash & Short Term Investments as of fiscal 2022. There were $917.55M in debt and $689.30M in liabilities at the time. Its Book Value Per Share was $28.90, while its Total Shareholder’s Equity was $3.36B.

Analysts Opinion

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for RMD is Buy with a score of 4.17.

Related Articles


Please enter your comment!
Please enter your name here

Latest Articles